1. CTNI-68. FIREFLY-1 (PNOC026): PHASE 2 STUDY OF PAN-RAF INHIBITOR TOVORAFENIB IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RAF-ALTERED RECURRENT OR PROGRESSIVE LOW-GRADE GLIOMA OR ADVANCED SOLID TUMORS. (14th November 2022) Authors: Kilburn, Lindsay; Landi, Daniel; Leary, Sarah; Ziegler, David; Baxter, Patricia; Franson, Andrea; McCowage, Geoffrey; Waanders, Angela; Van der Lugt, Jasper; Oren, Michal Yalon; Gerber, Nicolas; Gottardo, Nicholas; Khuong-Quang, Dong-Anh; Nysom, Karsten; Bailey, Simon; Driever, Pablo Hernáiz; Per... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗